Clinical Trials
All Clinical Trials - Page 15 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07096063N/ACompleted
Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk
Tirzepatide
- NCT07088718N/ACompleted
Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data
Tirzepatide
- NCT06606821Phase 4Recruiting
The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
Tirzepatide
- NCT06613854Phase 4Recruiting
Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes
Semaglutide
- NCT06564441Phase 1Completed
A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or Obesity
Survodutide
- NCT06588283Phase 3Completed
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
Tirzepatide
- NCT06269120N/ACompleted
SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary
Semaglutide
- NCT05663515N/ARecruiting
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Exenatide
- NCT06640972Phase 2Completed
Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
Tirzepatide
- NCT06588296Phase 3Completed
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
Tirzepatide
- NCT06634927Phase 1Completed
Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.
Semaglutide
- NCT06603571Phase 2Completed
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Tirzepatide
- NCT06604624Phase 3Completed
Semaglutide in Treatment of Obesity
Semaglutide
- NCT06380426N/ARecruiting
A Multicenter Pharmacoepidemiological Cohort on Real Life Use of Semaglutide in Adolescents or Adults With Monogenic Obesity
Semaglutide
- NCT06605703Phase 4Completed
A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
Tirzepatide
- NCT06571383Phase 4Active Not Recruiting
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
Semaglutide
- NCT07816562Phase 3Recruiting
Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)
Gonadorelin
- NCT06592261Phase 1Completed
Graded Insulin Suppression Test P&F
Octreotide
- NCT06485089N/ACompleted
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
Tirzepatide
- NCT06584916Phase 3Completed
A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
Orforglipron
- NCT07280403N/ACompleted
Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss
Semaglutide
- NCT06446531Phase 1Recruiting
Prevention of Progression of Prediabetes, Obesity and CV Risk
Semaglutide
- NCT06484114N/AActive Not Recruiting
Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
Tirzepatide
- NCT06557811Phase 4Unknown
Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction
Semaglutide
- NCT06584006Phase 2Recruiting
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
Thymosin-Alpha-1
- NCT06573398Phase 2Not Yet Recruiting
Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC
Thymosin-Alpha-1
- NCT06748638Phase 4Unknown
Clinical Study on the Application of Lactulose Combined with Linaclotide in Bowel Preparation for Colonoscopy
Linaclotide
- NCT06449235Phase 4Unknown
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
Semaglutide
- NCT06536023Phase 1Completed
This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity
Mazdutide
- NCT06577090Phase 2Active Not Recruiting
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
Semaglutide
- NCT06225284Phase 2Recruiting
Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
Gonadorelin
- NCT06976372Phase 1Completed
A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or Obesity
Maridebart-Cafraglutide
- NCT06559527Phase 1Completed
A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function
Amycretin
- NCT06622187Phase 4Enrolling By Invitation
Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies
Desmopressin
- NCT06449625Phase 2Not Yet Recruiting
Semaglutide in Auto-HSCT
Semaglutide
- NCT06492135Phase 1Completed
A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the Body
Survodutide
- NCT06542874Phase 2Completed
A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
Amycretin
- NCT06565611Phase 2Active Not Recruiting
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Tirzepatide
- NCT06468748Phase 4Withdrawn
The Effects of Semaglutide on Body Composition and Performance in Military Personnel
Semaglutide
- NCT05965908Phase 3Completed
Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome
Liraglutide
- NCT06252623Phase 1Withdrawn
Exenatide For Reducing the Reinforcing Effects of Cocaine
Exenatide
- NCT06422624Phase 1Unknown
A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
Semaglutide
- NCT06555146N/AUnknown
Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy
Semaglutide
- NCT06559722Phase 3Unknown
A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes
Liraglutide
- NCT06533527Phase 4Completed
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
Tirzepatide
- NCT06501729N/ACompleted
Kissing as a Protective Factor Against Acidic pH in Saliva
Kisspeptin
- NCT06505395Phase 2Recruiting
A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)
Octreotide
- NCT06379217Phase 1Active Not Recruiting
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
Gonadorelin
- NCT06179303Phase 2Recruiting
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Gonadorelin
- NCT06184633Phase 4Active Not Recruiting
DUTCH Weight Control in Atrial Fibrillation Study
Semaglutide